NeoGenomics (NEO) COO receives new stock option and RSU grants

Rhea-AI Filing Summary

NeoGenomics Inc. reported that President & Chief Operating Officer Warren Stone received new equity awards. On March 1, 2026, he was granted 253,378 stock options and 152,594 restricted stock units, both vesting ratably over the first three anniversary dates of the grant.

The stock option grant was structured as a premium-price option, with the exercise price set at 110% of the February 27, 2026 closing share price. Footnotes also describe Mr. Stone’s existing stock options, restricted stock units, and performance stock units granted between 2022 and 2025, which vest over multi‑year and performance-based schedules.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stone Warren

(Last) (First) (Middle)

9490 NEOGENOMICS WAY

(Street)

FORT MYERS FL 33912

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NEOGENOMICS INC [ NEO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres & Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								147,714	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$10.81(1)	03/01/2026		A		253,378		(2)	03/01/2036	Common Stock	253,378	$0	253,378	D
Restricted Stock Unit	$0	03/01/2026		A		152,594		(3)	(4)	Common Stock	152,594	$0	152,594	D
Stock Option (Right to Buy)	$11.21							(5)	12/01/2029	Common Stock	166,113		166,113	D
Stock Option (Right to Buy)	$19.65							(6)	05/11/2030	Common Stock	53,969		53,969	D
Performance Stock Unit	$0							05/11/2026(7)	(4)	Common Stock	21,204		21,204	D
Restricted Stock Unit	$0							(8)	(4)	Common Stock	9,613		9,613	D
Stock Option (Right to Buy)	$16.45							(9)	02/23/2034	Common Stock	42,344		42,344	D
Performance Stock Unit	$0							02/23/2027(10)	(4)	Common Stock	25,330		25,330	D
Restricted Stock Unit	$0							(11)	(4)	Common Stock	8,443		8,443	D
Stock Option (Right to Buy)	$13.96							(12)	05/02/2034	Common Stock	29,976		29,976	D
Performance Stock Unit	$0							05/02/2027(13)	(4)	Common Stock	17,908		17,908	D
Restricted Stock Unit	$0							(14)	(4)	Common Stock	17,908		17,908	D
Restricted Stock Unit	$0							01/13/2026	(4)	Common Stock	59,382		59,382	D
Stock Option (Right to Buy)	$13.05(15)							(16)	02/21/2035	Common Stock	143,266		143,266	D
Restricted Stock Unit	$0							(17)	(4)	Common Stock	56,212		56,212	D
Stock Option (Right to Buy)	$10.44(18)							(19)	04/01/2035	Common Stock	94,518		94,518	D
Restricted Stock Unit	$0							(20)	(4)	Common Stock	52,687		52,687	D

Explanation of Responses:

1. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 multiplied by 110%.

2. On March 1, 2026, Mr. Stone was granted 253,378 stock options. The options vest ratably over the first three anniversary dates of the grant date.

3. On March 1, 2026, Mr. Stone was granted 152,594 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

4. Once vested, the shares of common stock are not subject to expiration.

5. On December 1, 2022, Mr. Stone was granted 166,113 stock options. The options vest ratably over the first four anniversary dates of the grant date.

6. On May 11, 2023, Mr. Stone was granted 53,969 stock options. The options vest ratably over the first three anniversary dates of the grant date.

7. On May 11, 2023, Mr. Stone was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.

8. On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

9. On February 23, 2024, Mr. Stone was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.

10. On February 23, 2024, Mr. Stone was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

11. On February 23, 2024, Mr. Stone was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

12. On May 2, 2024, Mr. Stone was granted 29,976 stock options. The options vest ratably over the first three anniversary dates of the grant date.

13. On May 2, 2024, Mr. Stone was granted 17,908 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is26,862. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

14. On May 2, 2024, Mr. Stone was granted 17,905 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

15. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%

16. On February 21, 2025, Mr. Stone was granted 143,266 stock options. At the time of the grant, the options vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone's promotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these options was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.

17. On February 21, 2025, Mr. Stone was granted 84,317 restricted stock units. At the time of the grant, the restricted stock units vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone's promotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these restricted stock units was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grantdate.

18. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.

19. On April 1, 2025, Mr. Stone was granted 94,518 stock options. The options vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.

20. On April 1, 2025, Mr. Stone was granted 52,687 restricted stock units. The restricted stock units vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.

Remarks:

	/s/ Ali Olivo, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NeoGenomics (NEO) report for Warren Stone?

NeoGenomics reported that President & Chief Operating Officer Warren Stone received new equity awards. On March 1, 2026, he was granted stock options and restricted stock units that vest over several years as part of his executive compensation package.

How many stock options and RSUs did Warren Stone receive from NeoGenomics (NEO)?

Warren Stone received 253,378 stock options and 152,594 restricted stock units. Both awards were granted on March 1, 2026 and vest ratably over the first three anniversary dates of the grant, aligning his compensation with longer-term company performance.

What is a premium-price stock option in the NeoGenomics (NEO) Form 4?

A premium-price stock option has an exercise price set above the market price on the grant date. NeoGenomics set Warren Stone’s March 1, 2026 option exercise price at 110% of the February 27, 2026 closing share price, requiring additional share appreciation before intrinsic value exists.

How do Warren Stone’s new NeoGenomics (NEO) equity awards vest?

The March 1, 2026 stock options and restricted stock units vest ratably over the first three anniversary dates of the grant. This means portions of each award vest in equal installments on each of the first, second, and third anniversaries, encouraging multi‑year retention.

What performance stock units does Warren Stone hold at NeoGenomics (NEO)?

Footnotes show Warren Stone holds performance stock units granted in 2023 and 2024. These units can vest based on achieving specified share price growth and revenue growth goals measured over defined periods, with maximum share amounts possible if higher performance criteria are met.

Did the NeoGenomics (NEO) Form 4 show any stock sales by Warren Stone?

The Form 4 summarizes equity awards and existing holdings for Warren Stone but does not report any stock sales. The primary new reportable events are grants of stock options and restricted stock units awarded on March 1, 2026 as part of his executive compensation.